Индекс накопления липидов (lipid accumulation product, LAP) - современный клинико-биохимический маркер ожирения у человека

Бесплатный доступ

Ожирение является важной медико-социальной проблемой, поскольку представляет серьезную угрозу для здоровья населения вследствие частого развития тяжелых сопутствующих заболеваний. Самым опасным видом ожирения считается висцеральное ожирение. Своевременная диагностика висцерального ожирения как на скрининговых осмотрах условно здорового населения, так и у лиц с сердечно-сосудистыми заболеваниями становится важным направлением как первичной, так и вторичной профилактики. В обзоре рассматривается современный маркер висцерального ожирения - индекс накопления липидов (lipid accumulation product - LAP). Этот индекс, предложенный H.S. Kahn в 2005 г., рассчитывается на основании двух переменных - обхвата талии (см) и уровня триглицеридов (ммоль/л), измеренного натощак. Одновременное использование биохимического и антропометрического показателей при расчете индекса LAP позволяет не только оценивать характер распределения жира в организме, но и отражать функциональное состояние жировой ткани...

Еще

Индекс накопления липидов (lap), обхват талии, триглицериды, индекс массы тела, ожирение, метаболический синдром, сердечно-сосудистые заболевания

Короткий адрес: https://readera.org/142220679

IDR: 142220679   |   DOI: 10.21668/health.risk/2019.2.18

Список литературы Индекс накопления липидов (lipid accumulation product, LAP) - современный клинико-биохимический маркер ожирения у человека

  • Kahn H.S. Estimating adult metabolic risk from a lipid accumulation product//Am. J. Epidemiol. -2004. -Vol. 159, № 11. -P. 14.
  • Kahn H.S. The lipid accumulation product is better than body mass index for identifying diabetes//Am. J. Epidemiol. -2005. -Vol. 161, № 11. -P. 51.
  • Kahn H.S. The «lipid accumulation product» performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison//BMC Cardiovasc. Disord. -2005. -Vol. 5. -P. 26 DOI: 10.1186/1471-2261-5-26
  • Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?/I. Lemieux, A. Pascot, C. Couillard, B. Lamarche, A. Tchernof, N. Almeras //Circulation. -2000. -Vol. 102, № 2. -P. 179-184.
  • Kahn H.S., Valdez R. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerols//Am. J. Clin. Nutr. -2003. -Vol. 78, № 5. -P. 928-934 DOI: 10.1093/ajcn/78.5.928
  • Shah N.R., Braverman E.R. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin//PLoS One. -2012. -Vol. 7, № 4. -P. e33308
  • DOI: 10.1371/journal.pone.0033308
  • Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences//Obes. Rev. -2010. -Vol. 11, № 1. -P. 11-18
  • DOI: 10.1111/j.1467-789X.2009.00623.x
  • Ebbert J.O., Jensen M.D. Fat depots, free fatty acids, and dyslipidemia//Nutrients. -2013. -Vol. 5, № 2. -P. 498-508
  • DOI: 10.3390/nu5020498
  • Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk/J.P. Després, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose //Arterioscler. Thromb. Vasc. Biol. -2008. -Vol. 28, № 6. -P. 1039-1049
  • DOI: 10.1161/ATVBAHA.107.159228
  • Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study/H. Wang, A. Liu, T. Zhao, X. Gong, T. Pang, Y. Zhou //BMJ Open. -2017. -Vol. 7, № 9. -P. e016062
  • DOI: 10.1136/bmjopen-2017-016062
  • Ray L., Ravichandran K., Nanda S.K. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population//Metab. Syndr. Relat. Disord. -2018. -Vol. 16, № 5. -P. 240-245
  • DOI: 10.1089/met.2017.0119
  • Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese/R. Li, Q. Li, M. Cui, Z. Yin, L. Li, T. Zhong //J. Diabetes Investig. -2018. -Vol. 9, № 2. -P. 411-418
  • DOI: 10.1111/jdi.12708
  • Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals/C. Xia, R. Li, S. Zhang, L. Gong, W. Ren, Z. Wang, Q. Li//Eur. J. Clin. Nutr. -2012. -Vol. 66, № 9. -P. 1035-1038
  • DOI: 10.1038/ejcn.2012.83
  • Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance/M. Mazidi, A.P. Kengne, N. Katsiki, D.P. Mikhailidis, M. Banach//J. Diabetes Complications. -2018. -Vol. 32, № 3. -P. 266-270
  • DOI: 10.1016/j.jdiacomp.2017.10.007
  • Wakabayashi I., Daimon T. A strong association between lipid accumulation product and diabetes mellitus in Japanese women and men//J. Atheroscler. Thromb. -2014. -Vol. 21, № 3. -P. 282-288
  • DOI: 10.5551/jat.20628
  • A simple index of lipid overaccumulation is a good marker of liver steatosis/G. Bedogni, H.S. Kahn, S. Bellentani, C. Tiribelli//BMC Gastroenterol. -2010. -Vol. 10. -P. 98
  • DOI: 10.1186/1471-230X-10-98
  • Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults/H. Dai, W. Wang, R. Chen, Z. Chen, Y. Lu, H. Yuan//Nutr. Metab. (Lond). -2017. -Vol. 14. -P. 49
  • DOI: 10.1186/s12986-017-0206-2
  • Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in patients with adult growth hormone deficiency/L. Chan, H. Xue, Z. Xiaoya, X. Jiajia, R. Wei, L. Linman //Exp. Clin. Endocrinol. Diabetes. -2016. -Vol. 124, № 4. -P. 220-224
  • DOI: 10.1055/s-0035-1569402
  • Lipid accumulation product (LAP) as an index of metabolic and hormonal disorders in aging men/I. Rotter, A. Rył, A. Szylińska, W. Pawlukowska, A. Lubkowska, M. Laszczyńska//Exp. Clin. Endocrinol. Diabetes. -2017. -Vol. 125, № 3. -P. 176-182
  • DOI: 10.1055/s-0042-116071
  • Comparison of lipid accumulation product with body mass index as an indicator of hypertension risk among Mongolians in China/X. Gao, G. Wang, A. Wang, T. Xu, W. Tong, Y. Zhang//Obes. Res. Clin. Pract. -2013. -Vol. 7, № 4. -P. 308-314
  • DOI: 10.1016/j.orcp.2012.02.002
  • Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population/H. Wang, Y. Chen, G. Sun, P. Jia, H. Qian, Y. Sun//Postgrad. Med. -2018. -Vol. 130, № 3. -P. 325-333
  • DOI: 10.1080/00325481.2018.1444901
  • Lipid accumulation product and hypertension related to stroke: a 9.2-year prospective study among Mongolians in China/C. Zhong, W. Xia, X. Zhong, T. Xu, H. Li, M. Zhang //J. Atheroscler. Thromb. -2016. -Vol. 23, № 7. -P. 830-838
  • DOI: 10.5551/jat.33514
  • Visceral adiposity and renal function: an observational study from SPECT-China/K. Zhang, Q. Li, Y. Chen, N. Wang, Y. Lu//Lipids Health Dis. -2017. -Vol. 16. -P. 205
  • DOI: 10.1186/s12944-017-0597-0
  • Visceral adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the rural population in northeast China/D. Dai, Y. Chang, Y. Chen, S. Chen, S. Yu, X. Guo, Y. Sun//Int. J. Environ. Res. Public Health. -2016. -Vol. 13, № 12. -P. 1231
  • DOI: 10.3390/ijerph13121231
  • Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults: The ATTICA study/I. Kyrou, D.B. Panagiotakos, G.M. Kouli, E. Georgousopoulou, C. Chrysohoou, C. Tsigos //Atherosclerosis. -2018. -Vol. 279. -P. 10-16
  • DOI: 10.1016/j.atherosclerosis.2018.10.015
  • Lipid accumulation product index as visceral obesity indicator in psoriasis: a case-control study/S. Ganguly, L. Ray, S. Kuruvila, S.K. Nanda, K. Ravichandran//Indian J. Dermatol. -2018. -Vol. 63, № 2. -P. 136-140
  • DOI: 10.4103/ijd.IJD_315_16
  • Glintborg D., Andersen M. Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review//Curr. Opin. Obstet. Gynecol. -2017. -Vol. 29, № 6. -P. 390-396
  • DOI: 10.1097/GCO.0000000000000410
  • Is lipid accumulation product associated with an atherogenic lipoprotein profile in Brazilian subjects?/F.C. Cartolano, C. Pappiani, M.C.P. Freitas, A.M. Figueiredo Neto, A.A.F. Carioca, N.R.T. Damasceno//Arq. Bras. Cardiol. -2018. -Vol. 110, № 4. -P. 339-347
  • DOI: 10.5935/abc.20180054
  • Body fat and blood rheology: Evaluation of the association between different adiposity indices and blood viscosity/C. Tripolino, C. Irace, C. Carallo, F.B. Scavelli, A. Gnasso//Clin. Hemorheol. Microcirc. -2017. -Vol. 65, № 3. -P. 241-248
  • DOI: 10.3233/CH-16172
  • Wakabayashi I. Associations of blood lipid-related indices with blood pressure and pulse pressure in middle-aged men//Metab. Syndr. Relat. Disord. -2015. -Vol. 13, № 1. -P. 22-28
  • DOI: 10.1089/met.2014.0093
  • Bhargava A. Dietary modifications and lipid accumulation product are associated with systolic and diastolic blood pressures in the women's health trial: Feasibility study in minority populations//Curr. Hypertens. Rep. -2018. -Vol. 20, № 6. -P. 50
  • DOI: 10.1007/s11906-018-0846-2
  • Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China/H. Wang, Y. Sun, Z. Li, X. Guo, S. Chen, N. Ye //BMC Cardiovasc. Disord. -2018. -Vol. 18, № 1. -P. 62
  • DOI: 10.1186/s12872-018-0798-0
  • Thyroid stimulating hormone within the reference range is associated with visceral adiposity index and lipid accumulation product: A population-based study of SPECT-China/Y. Chen, Y. Chen, N. Wang, C. Chen, X. Nie, Q. Li //Horm. Metab. Res. -2018. -Vol. 50, № 1. -P. 29-36
  • DOI: 10.1055/s-0043-122235
  • Wakabayashi I. Associations between heavy Alcohol drinking and lipid-related indices in middle-aged men//Alcohol. -2013. -Vol. 47, № 8. -P. 637-642
  • DOI: 10.1016/j.alcohol.2013.10.001
  • Effects of smoking and alcohol consumption on lipid profile in male adults in northwest rural China/X.X. Li, Y. Zhao, L.X. Huang, H.X. Xu, X.Y. Liu, J.J. Yang //Public Health. -2018. -Vol. 157. -P. 7-13
  • DOI: 10.1016/j.puhe.2018.01.003
  • Wakabayashi I. Smoking and lipid-related indices in patients with diabetes mellitus//Diabet Med. -2014. -Vol. 31, № 7. -P. 868-878
  • DOI: 10.1111/dme.12430
  • Associations of objectively measured sedentary behavior, light activity, and markers of cardiometabolic health in young women/A.N. Green, R. McGrath, V. Martinez, K. Taylor, D.R. Paul, C.A. Vella//Eur. J. Appl. Physiol. -2014. -Vol. 114, № 5. -P. 907-919
  • DOI: 10.1007/s00421-014-2822-0
  • Mario F.M., Graff S.K., Spritzer P.M. Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study//J. Endocrinol. Invest. -2017. -Vol. 40, № 4. -P. 377-384
  • DOI: 10.1007/s40618-016-0570-1
  • The lipid accumulation product is highly related to serum alanine aminotransferase level in male adults/B.L. Ji, R. Li, S.H. Zhang, L.L. Gong, Z.H. Wang, W. Ren, Q.F. Li//Nutr. Res. -2012. -Vol. 32, № 8. -P. 581-587
  • DOI: 10.1016/j.nutres.2012.06.019
  • Accuracy of plasma interleukin-18 and adiponectin concentrations in predicting metabolic syndrome and cardiometabolic disease risk in middle-age Brazilian men/A. De Oliveira, H.H. Hermsdorff, P.G. Cocate, E.C. Santos, J. Bressan, A.J. Natali//Appl. Physiol. Nutr. Metab. -2015. -Vol. 40, № 10. -P. 1048-1055
  • DOI: 10.1139/apnm-2014-0487
  • The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study/A.G. Ioachimescu, D.M. Brennan, B.M. Hoar, B.J. Hoogwerf//Obesity (Silver Spring). -2010. -Vol. 18, № 9. -P. 1836-1844
  • DOI: 10.1038/oby.2009.453
  • Bozorgmanesh M., Hadaegh F., Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study//Lipids Health Dis. -2010. -Vol. 9. -P. 45
  • DOI: 10.1186/1476-511X-9-45
  • Metabolic syndrome and its predictors in an urban population in Kenya: A cross sectional study/G. Omuse, D. Maina, M. Hoffman, J. Mwangi, C. Wambua, E. Kagotho //BMC Endocr. Disord. -2017. -Vol. 17, № 1. -P. 37
  • DOI: 10.1186/s12902-017-0188-0
  • Oh J.Y., Sung Y.A., Lee H.J. The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women//Diabet Med. -2013. -Vol. 30, № 4. -P. 436-442
  • DOI: 10.1111/dme.12052
  • Lipid accumulation product and metabolic syndrome: a population-based study in northern Iran, Amol/N. Motamed, S. Razmjou, G. Hemmasi, M. Maadi, F. Zamani//J. Endocrinol. Invest. -2016. -Vol. 39, № 4. -P. 375-382
  • DOI: 10.1007/s40618-015-0369-5
  • Anthropometric and central obesity indices as predictors of long-term cardiometabolic risk among Saudi young and middle-aged men and women/M.M. Abulmeaty, A.M. Almajwal, N.K. Almadani, M.S. Aldosari, A.A. Alnajim, S.B. Ali //Saudi Med. J. -2017. -Vol. 38, № 4. -P. 372-380
  • DOI: 10.15537/smj.2017.4.18758
  • Wakabayashi I. Influence of age and gender on lipid accumulation product and its relation to diabetes mellitus in Japanese//Clin. Chim. Acta. -2014. -Vol. 431. -P. 221-226
  • DOI: 10.1016/j.cca.2014.02.002
  • Chiang J.K., Koo M. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over//BMC Cardiovasc. Disord. -2012. -Vol. 12. -P. 78
  • DOI: 10.1186/1471-2261-12-78
  • Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults/H.S. Kahn, K.M. Bullard, L.E. Barker, G. Imperatore//PLoS One. -2012. -Vol. 7, № 11. -P. e50428
  • DOI: 10.1371/journal.pone.0050428
  • Multimarker analysis for new biomarkers in relation to central arterial stiffness and hemodynamics in a Chinese community-dwelling population/S. Fu, L. Luo, P. Ye, W. Xiao//Angiology. -2015. -Vol. 66, № 10. -P. 950-956
  • DOI: 10.1177/0003319715573910
  • Novel indexes for diagnosing metabolic syndrome in apparently healthy Gujarati Asian Indians: a cross-sectional study/H. Joshi, K. Shah, P. Patel, J. Prajapati, M. Parmar, D. Doshi, S. Chaurushia//QJM. -2016. -Vol. 109, № 11. -P. 717-722
  • DOI: 10.1093/qjmed/hcw056
  • Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome/S. Xiang, F. Hua, L. Chen, Y. Tang, X. Jiang, Z. Liu//Exp. Clin. Endocrinol. Diabetes. -2013. -Vol. 121, № 2. -P. 115-118
  • DOI: 10.1055/s-0032-1333261
  • Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population/M.J. Taverna, M.T. Martínez-Larrad, G.D. Frechtel, M. Serrano-Ríos//Eur. J. Endocrinol. -2011. -Vol. 164, № 4. -P. 559-567
  • DOI: 10.1530/EJE-10-1039
  • Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study/F. Hosseinpanah, M. Barzin, H. Erfani, S. Serahati, F. Ramezani Tehrani, F. Azizi//Clin. Endocrinol. (Oxf). -2014. -Vol. 81, № 1. -P. 52-57
  • DOI: 10.1177/2047487314558771
  • Tian S., Xu Y., Han F. Higher predictability of the lipid accumulation product than commonly used anthropometric parameters partly due to its definition//Clin. Nutr. -2017. -Vol. 36, № 3. -P. 909
  • DOI: 10.1016/j.clnu.2017.03.001
  • Bozorgmanesh M., Hadaegh F., Azizi F. Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study//Lipids Health Dis. -2010. -Vol. 9. -P. 100
  • DOI: 10.1186/1476-511X-9-100
  • Kavaric N., Klisic A., Ninic A. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?//J. Clin. Lab. Anal. -2018. -Vol. 32, № 3. -P. e22283
  • DOI: 10.1002/jcla.22283
  • Visceral adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese/R. Li, Q. Li, M. Cui, Z. Ying, L. Li, T. Zhong //Sci. Rep. -2017. -Vol. 7, № 1. -P. 7951
  • DOI: 10.1038/s41598-017-07811-7
  • Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly/A.K. Roriz, L.C. Passos, C.C. De Oliveira, M. Eickemberg, P.A. Moreira, L.R. Sampaio//PLoS One. -2014. -Vol. 9, № 7. -P. e103499
  • DOI: 10.1371/journal.pone.0103499
  • Fatty liver index and lipid accumulation product can predict metabolic syndrome in subjects without fatty liver disease/Y.L. Cheng, Y.J. Wang, K.H. Lan, T.I. Huo, Y.H. Huang, C.W. Su //Gastroenterol. Res. Pract. -2017. -Vol. 2017. -P. 9279836
  • DOI: 10.1155/2017/9279836
  • Usefulness of cardiometabolic index for the estimation of ischemic stroke risk among general population in rural China/H. Wang, Y. Chen, X. Guo, Y. Chang, Y. Sun//Postgrad. Med. -2017. -Vol. 129, № 8. -P. 834-841
  • DOI: 10.1080/00325481.2017.1375714
  • Association of IL-1β, IL-1Ra and FABP1 gene polymorphisms with the metabolic features of polycystic ovary syndrome/N. Rashid, A. Nigam, P. Saxena, S.K. Jain, S. Wajid//Inflamm. Res. -2017. -Vol. 66, № 7. -P. 621-636
  • DOI: 10.1007/s00011-017-1045-3
  • Основные антропометрические индексы и сахарный диабет 2 типа в российской популяции/О.М. Драпкина, Р.Н. Шепель, С.А. Шальнова, А.Д. Деев, Ю.А. Баланова, С.Е. Евстифеева //Рациональная фармакотерапия в кардиологии. -2018. -Т. 14, № 5. -С. 725-732.
  • Антропометрические индексы и их связь с ишемической болезнью сердца/С.А. Шальнова, А.Д. Деев, Г.А. Муромцева, Ю.А. Баланова, А.Э. Имаева, А.В. Капустина, С.Е. Евстифеева //Кардиоваскулярная терапия и профилактика. -2018. -Т. 17, № 3. -С. 11-16.
  • Хрипун И.А., Воробьев С.В., Коган М.И. Новый маркер метаболических нарушений у мужчин с сахарным диабетом 2-го типа//Медицинский вестник Юга России. -2016. -№ 1. -С. 84-86.
  • Корноухова Л.А. Значение предикторов кардиоваскулярных нарушений у пациентов с абдоминальным ожирением, неалкогольной жировой болезнью печени и различными компонентами метаболического синдрома//Медицинский алфавит. -2017. -Т. 1, № 6. -С. 51-56.
  • Lipid accumulation product (LAP) as a criterion for the identification of the healthy obesity phenotype in postmenopausal women/F. Lwow, D. Jedrzejuk, A. Milewicz, L. Szmigiero//Exp Gerontol. -2016. -Vol. 82. -P. 81-87
  • DOI: 10.1016/j.exger.2016.06.007
  • Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype/T. Du, X. Yu, J. Zhang, X. Sun//Acta Diabetol. -2015. -Vol. 52, № 5. -P. 855-863
  • DOI: 10.1007/s00592-015-0715-2
  • The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article/H. Lin, L. Zhang, R. Zheng, Y. Zheng//Medicine (Baltimore). -2017. -Vol. 96, № 47. -P. e8838
  • DOI: 10.1097/MD.0000000000008838
Еще
Статья обзорная